Russia's sovereign wealth fund has filed for registration of Sputnik V in the European Union and expects it to be reviewed in February, the official account promoting the COVID-19 vaccine tweeted on Wednesday.
The Sputnik V and European Medical Agency (EMA) teams held a scientific review of the vaccine on Tuesday, the Sputnik V account said, adding the EMA will take a decision on the authorization of the vaccine based on the reviews. (https://bit.ly/39OQZDR)
The vaccine has already been approved in Argentina, Belarus, Serbia and other countries.
Some UK departing flights disrupted by NATS technical issue
At least 73 injured after Houthi rebels attack Saudi civilian and energy facilities
Suspect detained after sabotage attacks on Germany power grid
Nepal rescue focused on workers trapped in three tunnels
Indonesia reopens Jakarta airport, four others after Anak Krakatau ash clears
Russia hits Kyiv after brief pause for US envoys' visit, killing two
Kenya offers temporary amnesty to undocumented East Africans amid crackdown fears
7 Indonesian airports remain shut due to volcanic ash from Anak Krakatau
